Unique MicroRNA and mRNA Interactions in <i>EGFR</i>-Mutated Lung Adenocarcinoma

Unique MicroRNA and mRNA Interactions in <i>EGFR</i>-Mutated Lung Adenocarcinoma

The <i>EGFR</i> gene was one of the first molecules to be selected for targeted gene therapy. <i>EGFR</i>-mutated lung adenocarcinoma, which is responsive to <i>EGFR</i> inhibitors, is characterized by a distinct oncogenic pathway in which unique microRNA (miRNA)&...

Full description

Bibliographic Details
Main Authors: Sophia Subat, Kentaro Inamura, Hironori Ninomiya, Hiroko Nagano, Sakae Okumura, Yuichi Ishikawa
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Journal of Clinical Medicine
Subjects:
driver mutation
EGFR
integrative association
messenger RNA
molecular-targeted therapy
noncoding RNA
non-small-cell lung carcinoma (NSCLC)
precision medicine
tumorigenesis
tyrosine kinase inhibitor
Online Access:https://www.mdpi.com/2077-0383/7/11/419

Internet

https://www.mdpi.com/2077-0383/7/11/419

Similar Items